Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Tacrolimus for the Amelioration of Breast Cancer-related Lymphedema: a Randomized, Double-blind, Placebo-controlled Phase II/III Trial

NCT06306274 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT06306274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06306274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Tacrolimus for the Amelioration of Breast Cancer-related Lymphedema: a Randomized, Double-blind, Placebo-controlled Phase II/III Trial
Lead sponsor
Odense University Hospital
Phase
Phase 2/3
Overall status
Enrolling by invitation
Start date
September 9, 2024
Completion date
March 31, 2026
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema